fda approval of tirzepatide for weight loss Zepbound: FSU researcher available for context on newly approved treatment FDA-Approved Tirzepatide: A Game Changer

PlexusDx offers the Precision Peptide Genetic Test, which analyzes your genetic variants in peptide pathways including GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)

You can check eligibility through a brief three-question online quiz

Risk-benefit assessment : For patients with multiple cardiovascular risk factors or established cardiovascular disease, tirzepatide's demonstrated benefits for glycemic control, weight reduction, and improvement in cardiovascular risk factors should be weighed against theoretical long-term risks

Patients with a BMI of 35 or higher automatically qualify

[2] Centrally, these medications act on appetite-regulating centres in the hypothalamus, leading to reduced caloric intake and subsequent weight loss

Say goodbye to uneven skin tone and hello to a brighter, more confident you